Publicaciones en las que colabora con Paula Ortega Lopez (67)

2024

  1. A new class of polyphenolic carbosilane dendrimers binds human serum albumin in a structure-dependent fashion

    Scientific Reports, Vol. 14, Núm. 1

  2. Polyphenolic dendrimers as carriers of anticancer siRNA

    International Journal of Pharmaceutics, Vol. 658

2023

  1. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 3

  2. Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study

    International Journal of Pharmaceutics, Vol. 636

  3. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  4. Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols

    Colloids and Surfaces B: Biointerfaces, Vol. 227

  5. Ruthenium metallodendrimer against triple-negative breast cancer in mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 53

2022

  1. Dendrimers and Dendritic Materials against Infectious Diseases

    Pharmaceutics

  2. Heterofunctional carbosilane polyphenolic dendrons: new antioxidants platforms

    RSC Advances, Vol. 12, Núm. 17, pp. 10280-10288

  3. Heterofunctionalized polyphenolic dendrimers decorated with caffeic acid: Synthesis, characterization and antioxidant activity

    Sustainable Materials and Technologies, Vol. 33

2021

  1. Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons

    Biomacromolecules, Vol. 22, Núm. 11, pp. 4582-4591

  2. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

    Dalton Transactions, Vol. 50, Núm. 27, pp. 9500-9511

  3. Effect of the combination of levofloxacin with cationic carbosilane dendron and peptide in the prevention and treatment of staphylococcus aureus biofilms

    Polymers, Vol. 13, Núm. 13

  4. Erratum to: Antioxidant and antibacterial properties of carbosilane dendrimers functionalized with polyphenolic moieties (Pharmaceutics 2020, 12, 698)

    Pharmaceutics

  5. Investigación en nuevos fármacos frente a COVID-19

    COVID-19: un enfoque plural (Universidad de Alcalá), pp. 81-104

2020

  1. Antioxidant and antibacterial properties of carbosilane dendrimers functionalized with polyphenolic moieties

    Pharmaceutics, Vol. 12, Núm. 8, pp. 1-16

  2. CHAPTER 5: Poly(carbosilane) dendrimers and other silicon-containing dendrimers

    Monographs in Supramolecular Chemistry, Vol. 2020-January, Núm. 29, pp. 114-145

  3. Cationic Carbosilane Dendritic Systems as Promising Anti-Amyloid Agents in Type 2 Diabetes

    Chemistry - A European Journal, Vol. 26, Núm. 34, pp. 7609-7621

  4. Copper (II) metallodendrimers combined with pro-apoptotic sirnas as a promising strategy against breast cancer cells

    Pharmaceutics, Vol. 12, Núm. 8, pp. 1-14

  5. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer

    European Journal of Medicinal Chemistry, Vol. 199